AlphaCrest Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,879
| Closed | -$603K | – | 1092 |
|
|
2022
Q3 | $603K | Sell |
2,879
-3,522
| -55% | -$738K | 0.04% | 895 |
|
|
2022
Q2 | $1.51M | Buy |
6,401
+718
| +13% | +$169K | 0.07% | 471 |
|
|
2022
Q1 | $1.02M | Sell |
5,683
-2,313
| -29% | -$415K | 0.06% | 538 |
|
|
2021
Q4 | $1.73M | Sell |
7,996
-2,606
| -25% | -$563K | 0.06% | 506 |
|
|
2021
Q3 | $1.96M | Buy |
10,602
+4,289
| +68% | +$792K | 0.1% | 312 |
|
|
2021
Q2 | $1.13M | Buy |
+6,313
| New | +$1.13M | 0.05% | 600 |
|
|
2020
Q4 | – | Sell |
-2,529
| Closed | -$255K | – | 1281 |
|
|
2020
Q3 | $255K | Sell |
2,529
-3,101
| -55% | -$313K | 0.03% | 950 |
|
|
2020
Q2 | $681K | Sell |
5,630
-4,417
| -44% | -$534K | 0.11% | 259 |
|
|
2020
Q1 | $953K | Buy |
10,047
+4,469
| +80% | +$424K | 0.12% | 296 |
|
|
2019
Q4 | $491K | Sell |
5,578
-19,552
| -78% | -$1.72M | 0.04% | 795 |
|
|
2019
Q3 | $2M | Buy |
25,130
+3,287
| +15% | +$262K | 0.12% | 236 |
|
|
2019
Q2 | $1.71M | Buy |
21,843
+16,294
| +294% | +$1.27M | 0.15% | 194 |
|
|
2019
Q1 | $651K | Buy |
+5,549
| New | +$651K | 0.1% | 362 |
|